Cardinal Health
CAH · Health Care Distributors
$249.57
2.4%Henry Schein
HSIC · Health Care Distributors
$84.96
1.2%The short version
- Cardinal Health is the larger business, with $254.2B of revenue in fiscal 2026 against $13.2B for Henry Schein, about 19 times as much.
- Cardinal Health grew revenue faster (14.2%, against 4.0%).
- Henry Schein kept more of each dollar of sales as operating profit (5.0% operating margin, against 1.0% operating margin).
- Henry Schein turned more of its sales into free cash flow (4.4% FCF margin, against 1.8% FCF margin).
| Latest fiscal year | CAH · FY26 | HSIC · FY25 |
|---|---|---|
| Size | ||
| Market cap | $59.1B | $9.7B |
| Revenue | $254.2B | $13.2B |
| Free cash flow | $4.5B | $573M |
| Net income | $1.7B | $398M |
| Growth | ||
| Revenue growth | 14.2% | 4.0% |
| 5-year growth | 9.4% | 5.4% |
| Share count change | −2.1% | −4.7% |
| Profitability | ||
| Gross margin | 3.8% | 31.1% |
| Operating margin | 1.0% | 5.0% |
| Net margin | 0.7% | 3.0% |
| FCF margin | 1.8% | 4.4% |
| Return on capital | — | 7.5% |
| Return on equity | — | 12.0% |
| Balance sheet | ||
| Net debt | $4.0B | $3.0B |
| Net debt / EBITDA | 1.1x | 3.1x |
| Dividends and buybacks | $1.8B | $850M |
| Valuation & quality | ||
| P/E | — | 24.8x |
| Piotroski F-score | 6 | 6 |
FY17
CAH $130.0B
HSIC $12.5B
FY18
CAH $136.8B
HSIC $13.2B
FY19
CAH $145.5B
HSIC $10.0B
FY20
CAH $152.9B
HSIC $10.1B
FY21
CAH $162.5B
HSIC $12.4B
FY22
CAH $181.3B
HSIC $12.6B
FY23
CAH $205.0B
HSIC $12.3B
FY24
CAH $226.8B
HSIC $12.7B
FY25
CAH $222.6B
HSIC $13.2B
FY26
CAH $254.2B
HSIC —
CAH
HSIC
FY17
CAH 1.6%
HSIC 5.4%
FY18
CAH 0.1%
HSIC 4.6%
FY19
CAH 1.4%
HSIC 7.2%
FY20
CAH −2.7%
HSIC 5.3%
FY21
CAH 0.3%
HSIC 6.9%
FY22
CAH −0.3%
HSIC 5.9%
FY23
CAH 0.4%
HSIC 5.0%
FY24
CAH 0.6%
HSIC 4.9%
FY25
CAH 1.0%
HSIC 5.0%
FY26
CAH 1.0%
HSIC —
CAH
HSIC
FY17
CAH $797M
HSIC $483M
FY18
CAH $2.4B
HSIC $613M
FY19
CAH $2.4B
HSIC $578M
FY20
CAH $1.6B
HSIC $550M
FY21
CAH $2.0B
HSIC $631M
FY22
CAH $2.8B
HSIC $506M
FY23
CAH $2.4B
HSIC $353M
FY24
CAH $3.3B
HSIC $700M
FY25
CAH $1.9B
HSIC $573M
FY26
CAH $4.5B
HSIC —
CAH
HSIC
FY17
CAH 13.6%
HSIC 9.6%
FY18
CAH —
HSIC 10.7%
FY19
CAH —
HSIC 11.3%
FY20
CAH −36.7%
HSIC 10.2%
FY21
CAH 9.2%
HSIC 14.3%
FY22
CAH —
HSIC 11.5%
FY23
CAH —
HSIC 8.3%
FY24
CAH —
HSIC 7.2%
FY25
CAH —
HSIC 7.5%
FY26
CAH —
HSIC —
CAH
HSIC
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.